Omega-3 Triglyceride Fish Oil 1100 mg

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements4.8 (2,951 ratings)
Format:Softgel Quantity: 60 Softgel(s) · 60 servings
Goals
$29.95 $0.49 per serving

Product analysis

59 out of 100

Omega-3 Triglyceride Fish Oil 1100 mg supplies EPA and DHA, with its clearest support relating to blood fat balance. It offers good value for combined omega-3 intake, though it is less economical if DHA is your main priority.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The ingredient-form descriptions are incomplete, limiting a confident quality comparison. Clear active-fat amounts do not by themselves settle the quality of the oil or its forms.

Ingredient Transparency70

The amounts and relevant composition details are disclosed, making the active fats easier to compare. Form descriptions are incomplete, so that part of the label is less informative.

Value For Money75

The combined EPA and DHA offer good value, with EPA also comparing favorably on cost. DHA alone is relatively expensive, so value depends on which active fats you want.

Customer Satisfaction89

Customer ratings are very positive across a large number of buyers. The breadth of feedback makes the satisfaction picture more dependable without proving a health benefit.

Product Focus68

The clearest connection is to blood fat balance, while the many other proposed uses have more mixed or conditional support. The active EPA and DHA amounts are more useful for judging that purpose than total oil weight.

Format
Softgel
Container
60 Softgel(s)
Per serving
$0.49
Customer rating
4.8 · 2,951 ratings
Report analysis

Goals

Impact
Highest effect
B Ingredient FitC- PathwaysA+ EvidenceA+ Formulation Logic
EPA (Eicosapentaenoic Acid) · 729 mg

EPA provides the main connection to triglyceride-related support, while DHA has limited lipid and vascular-surrogate evidence. Their declared amounts are considered as alternatives in the saved result, without adding their contributions or assuming synergy. The 729 mg EPA serving receives partial amount recognition. These findings do not transfer prescription EPA outcomes or establish routine cardiovascular-event prevention.

How this product is rated for Heart Health

Ingredient fit78

The relevant ingredients receive partial amount recognition. The formula’s other actives and links to additional goals also influence its focus.
Goal fit
The recognized ingredients are focused on relevant roles, although links to other goals reduce this product’s focus here.
Dose adequacy
The included serving amounts receive partial recognition; smaller or undisclosed amounts limit the comparison.

Pathways58

The strongest recognized contribution is to triglyceride metabolism. Coverage remains concentrated on this route.
Depth
The strongest recognized connection is to triglyceride metabolism.
Breadth
Coverage is concentrated on triglyceride metabolism; the other routes do not reach the supplied threshold.

Evidence100

EPA leads the saved evidence finding for triglyceride-related support, without establishing routine cardiovascular-event prevention. The included preparations are recognized as studied.
Evidence strength
EPA leads the saved evidence finding for triglyceride-related support, without establishing routine cardiovascular-event prevention.
Studied preparation
The included preparations are recognized as studied in the saved findings, without establishing form superiority.

Formulation logic100

No unmet required partner or configured conflict was identified. Included ingredients meet the saved amount threshold.
Partner coverage
The supplied findings identify no unmet required partner for the included ingredients; this does not establish synergy.
Conflicts
No configured ingredient conflict was matched in the supplied findings.
Effective doses
The ingredients included in this check meet its amount threshold, without establishing proven clinical efficacy at those amounts.
Study evidence
Cardiovascular Support
Impact
High effect
B Ingredient FitC PathwaysB+ EvidenceA+ Formulation Logic
Fish Oil · 1326 mg

EPA and DHA provide the main connection through triglyceride metabolism. Their declared active amounts contribute separately; total oil weight does not establish the same exposure. Supporting studies concern blood markers in specific populations and do not establish prevention of cardiovascular events.

How this product is rated for Cardiovascular Support

Ingredient fit76

EPA declared active gives the formula a clear connection to cardiovascular support. The declared amounts provide partial support, with smaller or unresolved amounts limiting the contribution.
Goal fit
EPA declared active gives the formula a clear connection to cardiovascular support.
Dose adequacy
The declared amounts provide partial support, with smaller or unresolved amounts limiting the contribution.

Pathways60

The strongest saved connection is triglyceride metabolism. One aspect reaches substantial coverage; support across other aspects is limited or absent.
Depth
The strongest saved connection is triglyceride metabolism.
Breadth
One aspect reaches substantial coverage; support across other aspects is limited or absent.

Evidence83

The supplied studies support specific marker or nutrient roles, with the limitations described for the relevant ingredients.
Evidence strength
EPA declared active provides the strongest amount-qualified evidence connection, subject to its population and outcome limitations.
Studied preparation
The preparations that qualify by amount match those accepted in the supplied evidence; this does not establish superiority over other forms.

Formulation logic100

The contributing ingredients work independently or have the partners required by the supplied findings. No listed formulation conflict was identified in the supplied facts.
Partner coverage
The contributing ingredients work independently or have the partners required by the supplied findings.
Conflicts
No listed formulation conflict was identified in the supplied facts.
Effective doses
All contributing ingredients meet the saved minimum amount check; this is not a guarantee of clinical benefit.
Study evidence
Fish Oil Supportive 185 studies
Inflammation
Impact
Moderate effect
C+ Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Fish Oil · 1326 mg

EPA and DHA are marine fats that may lower some markers of inflammation. That offers a possible benefit for this goal, although a change in blood markers doesn't necessarily mean noticeable symptom relief. The separately declared EPA and DHA amounts describe the active fats more usefully than total fish-oil weight; a broad, reliable clinical benefit remains uncertain.

How this product is rated for Inflammation

Ingredient fit65

DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) are relevant to this goal, with benefits limited by ingredient-specific context. Some usable amounts remain unresolved.
Goal fit
DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) are relevant to this goal, with benefits limited by ingredient-specific context.
Dose adequacy
The selected serving declares DHA (docosahexaenoic acid) 275 mg, EPA (eicosapentaenoic acid) 729 mg. Some amounts remain unresolved.

Pathways15

EPA and DHA relate to fatty-acid signals involved in inflammation. These roles do not guarantee symptom relief.
Depth
EPA and DHA relate to fatty-acid signals involved in inflammation.
Breadth
The main connection is through marine fatty acids; this does not imply broad symptom relief.

Evidence70

EPA and DHA may lower some inflammation markers; this does not guarantee noticeable symptom relief. The identified ingredient forms provide relevant context, though form alone cannot guarantee a benefit.
Evidence strength
EPA and DHA may lower some inflammation markers; this does not guarantee noticeable symptom relief.
Studied preparation
The identified ingredient forms provide relevant context, though form alone cannot guarantee a benefit.

Formulation logic100

No additional partner is identified as necessary for the relevant ingredients. No particular ingredient conflict is identified.
Partner coverage
No additional partner is identified as necessary for the relevant ingredients.
Conflicts
No particular ingredient conflict is identified.
Effective doses
The declared amounts provide a basis for comparison, without showing that the serving will produce an anti-inflammatory benefit.
Study evidence
Fish Oil Supportive 68 studies
Impact
High effect
B Ingredient FitC PathwaysB EvidenceA+ Formulation Logic
EPA (Eicosapentaenoic Acid) · 729 mg

DHA is a structural component of the retina, and fish oil supplies both DHA and EPA. That structural role does not establish improved vision from routine supplementation. Trials of EPA and DHA did not show an overall added benefit for age-related macular degeneration or an advantage over placebo for moderate-to-severe dry eye.

How this product is rated for Eye Health

Ingredient fit77

The fish oil declares EPA and DHA separately, with EPA closer to its comparison reference than DHA.
Goal fit
The formula includes ingredients considered for vision alongside a broader nutritional focus.
Dose adequacy
Declared amounts provide uneven coverage of the reference ranges; these ranges do not establish a proven routine vision dose.

Pathways60

The recorded findings concentrate on retinal and lens antioxidant defense. Other visual functions receive little or no coverage.
Depth
The strongest recorded coverage concerns retinal and lens antioxidant defense, without establishing a corresponding improvement in vision.
Breadth
Only one of the listed eye-function areas reaches the comparison’s coverage target; the findings do not support broad visual-performance claims.

Evidence79

The recorded evidence favors EPA over DHA, while the supplied trials do not establish routine adult vision improvement.
Evidence strength
EPA (Eicosapentaenoic Acid) drives the strongest recorded evidence finding, but the supplied context limits transfer to routine vision improvement.
Studied preparation
EPA matches a recognized preparation, while DHA lacks the same preparation match in the saved findings.

Formulation logic100

No missing partners or configured conflicts were identified. Amounts qualify unevenly where the supplied findings identify low or unresolved contributions.
Partner coverage
No missing ingredient partner was identified for the counted contributions; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients meet the comparison’s amount threshold, which is not a clinically proven effective dose.
Study evidence
Metabolism Support
Impact
Moderate effect
D+ Ingredient FitD- PathwaysA- EvidenceA+ Formulation Logic
Omega-3 · 86 mg

Whether omega-3 makes your body burn more calories is unclear for adults generally. Its possible effects on resting energy use vary across groups of people, so the amount in a serving can't predict a metabolism boost for you. That uncertainty also prevents a promise of lasting weight or fat loss.

How this product is rated for Metabolism Support

Ingredient fit50

Omega-3's connection to insulin sensitivity doesn't guarantee higher everyday energy expenditure.
Goal fit
Omega-3's connection to insulin sensitivity doesn't guarantee higher everyday energy expenditure.
Dose adequacy
Omega-3 1186 mg is declared per serving; this amount is a comparison quantity, not a guarantee of increased calorie burning.

Pathways41

The connection centers on particular metabolic processes rather than a broad effect across several ways to burn calories.
Depth
Omega-3's connection to insulin sensitivity doesn't guarantee higher everyday energy expenditure.
Breadth
The connection centers on particular metabolic processes rather than a broad effect across several ways to burn calories.

Evidence89

Omega-3's connection to insulin sensitivity doesn't guarantee higher everyday energy expenditure.
Evidence strength
Omega-3's connection to insulin sensitivity doesn't guarantee higher everyday energy expenditure.
Studied preparation
The ingredient preparation matches the available comparison information; preparation compatibility alone doesn't predict a metabolism boost.

Formulation logic100

No particular ingredient conflict is identified in these product details.
Partner coverage
No missing required ingredient partner is identified for the ingredients with known contributions.
Conflicts
No particular ingredient conflict is identified in these product details.
Effective doses
The declared ingredient quantities allow comparisons, but reaching a comparison amount doesn't guarantee increased calorie burning.
Study evidence
Omega-3 Supportive 42 studies
Joint Health
Impact
High effect
B- Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Omega-3 · 86 mg

Omega-3 fatty acids, including EPA and DHA, may provide small improvements in joint pain, stiffness or function in some inflammatory-joint and osteoarthritis settings. Findings are mixed, with important large trials showing no benefit. The evidence concerns sustained study regimens, so a label serving does not establish the same exposure or outcome, and it does not show cartilage repair or prevention. The 275 mg DHA per serving falls below the saved substantial-contribution threshold.

How this product is rated for Joint Health

Ingredient fit74

Omega-3 and EPA supply the counted contributions.
Goal fit
Omega-3 and EPA supply the counted contributions.
Dose adequacy
Omega-3 and EPA contribute partially; DHA falls below the saved threshold.

Pathways17

Inflammation control receives the strongest saved coverage. Inflammation control has limited coverage below the saved breadth criterion.
Depth
Inflammation control receives the strongest saved coverage; this does not establish structural repair.
Breadth
Inflammation control has limited coverage below the saved breadth criterion.

Evidence69

Omega-3 anchors the saved evidence finding, with population, regimen and preparation limits on expected symptom benefit.
Evidence strength
Omega-3 anchors the saved evidence finding; the supplied clinical limitations remain relevant.
Studied preparation
The counted preparations are accepted in the saved finding; this does not establish identical clinical effects across products.

Formulation logic100

The counted ingredients work independently or have their required partner; no configured conflict was found.
Partner coverage
The counted ingredients work independently or have their required partner; no extra combination benefit is established.
Conflicts
No configured ingredient conflict was found.
Effective doses
All 2 counted ingredients provide meaningful amounts under the saved criteria.
Study evidence
Omega-3 Supportive 40 studies

Ingredients

IngredientAmount per servingScore
Calories
15 Calorie(s)
Calories from Fat
10 Calorie(s)
Total Fat
1.5 Gram(s)
Molecularly distilled Fish Oil
1326 mg 83
Total Omega-3 Fatty Acids
1100 mg 78
Eicosapentaenoic Acid
729 mg 82
Docosahexaenoic Acid
275 mg 71
Other Omega-3 Fatty Acids
86 mg 78
Gluten Free Adults 18–50 Dairy Free
Report overview
B+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB+ Value
A serving provides 729 mg of EPA, about 55% of the fish oil. It is in triglyceride form, and the whole-product serving price works out to about $0.68 per gram of EPA.
How this ingredient is rated

Active Ingredient Quality & Bioavailability83

The EPA is in triglyceride form. EPA makes up about 55% of the 1326 mg of fish oil per serving. Tocopherol is identified as an antioxidant; its presence does not measure the oil’s oxidation.
Molecular Form and Bioavailability
The EPA is in triglyceride form.
EPA Concentration Density
EPA makes up about 55% of the 1326 mg of fish oil per serving.
Oxidation Protection
Tocopherol is identified as an antioxidant; its presence does not measure the oil’s oxidation.

Dose, Safety & Label Transparency82

Each serving has 729 mg of EPA and 275 mg of DHA. The oil is described as purified; a qualifying third-party contaminant-testing claim is not confirmed in the saved information.
Absolute EPA Dose per Serving
Each serving provides 729 mg of EPA, a higher amount.
EPA-Centric Ratio
Each serving has 729 mg of EPA and 275 mg of DHA, so EPA is higher.
Purity and Contaminant Testing
The oil is described as purified; a qualifying third-party contaminant-testing claim is not confirmed in the saved information.

Value80

Based on the whole-product serving price, the cost works out to about $0.68 per gram of EPA.
Price per Gram of EPA
Based on the whole-product serving price, the cost works out to about $0.68 per gram of EPA.
Fish Oil · 1326 mg OverallScore83
B- Active Ingredient Quality & BioavailabilityA Dose, Safety & Label TransparencyB+ Value
Each serving provides 729 mg of EPA and 275 mg of DHA from 1,326 mg of fish oil. The oil is identified as triglyceride, and EPA and DHA together make up about 75.7% of the oil.
How this ingredient is rated

Active Ingredient Quality & Bioavailability74

The evaluation records a triglyceride-form claim. The fish oil is described as molecularly distilled.
Omega-3 Molecular Form
The evaluation records a triglyceride-form claim.
Purification & Filtration Method
The fish oil is described as molecularly distilled.
Third-Party Purity & Potency Verification
The saved facts do not record an independent-testing claim.
Source & Sustainability
Alaska pollock is identified as a source; no qualifying sustainability claim is recorded.

Dose, Safety & Label Transparency94

A serving provides 1,004 mg of EPA and DHA combined. EPA and DHA together account for about 75.7% of the 1,326 mg of fish oil per serving. A qualifying antioxidant is recorded.
Total Active Omega-3 Dose (EPA + DHA)
A serving provides 1,004 mg of EPA and DHA combined.
Omega-3 Potency & Concentration
EPA and DHA together account for about 75.7% of the 1,326 mg of fish oil per serving.
EPA & DHA Individual Disclosure
EPA and DHA are listed separately at 729 mg and 275 mg per serving, respectively.
Oxidation Protection (Stabilizers)
The evaluation records a qualifying antioxidant, though its identity is not specified in the saved facts.

Value80

The whole-product serving price works out to about $0.50 per gram of EPA and DHA combined.
Cost Per Gram of Active EPA + DHA
The whole-product serving price works out to about $0.50 per gram of EPA and DHA combined.
Omega-3 · 1100 mg OverallScore78
B- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value
A serving of one softgel lists 729 mg EPA and 275 mg DHA in triglyceride form. Together they make up about 75.7% of the 1,326 mg of oil and cost about $0.50 per gram.
How this ingredient is rated

Active Ingredient Quality & Bioavailability72

The omega-3 is reported in triglyceride form. Antioxidant inclusion is not established.
Molecular Form & Absorption Potential
The omega-3 is reported in triglyceride form.
Source Purity & Oxidative Protection
Fish oil is listed, but antioxidant inclusion is not established in the saved facts.

Dose, Safety & Label Transparency73

EPA and DHA are listed separately and account for about 75.7% of the stated oil amount. A testing claim is recorded without an established qualifying certification or available analysis certificate.
EPA & DHA Label Specificity
A serving of one softgel lists 729 mg EPA and 275 mg DHA separately.
Active Ingredient Concentration
EPA and DHA together make up about 75.7% of the 1,326 mg of oil per serving.
Third-Party Purity Verification
A testing claim is recorded, but a qualifying certification or available analysis certificate is not established in the saved facts.

Value100

A whole-product serving costs about $0.50 and provides 1,004 mg of EPA plus DHA.
Price per 1000mg of EPA+DHA
At the listed price, EPA plus DHA costs about $0.50 per gram, based on the labeled serving.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  2. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  3. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  4. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  5. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  6. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  7. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  8. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  9. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsEye Health forEPA (Eicosapentaenoic Acid)
  10. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  11. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  12. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  13. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  14. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  15. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  16. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsInflammation forFish Oil
  17. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsInflammation forFish Oil
  18. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsInflammation forFish Oil
  19. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsInflammation forFish Oil
  20. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledInflammation forFish Oil